Nanofibers for Biomedical and Healthcare Applications.


Journal

Macromolecular bioscience
ISSN: 1616-5195
Titre abrégé: Macromol Biosci
Pays: Germany
ID NLM: 101135941

Informations de publication

Date de publication:
02 2019
Historique:
received: 05 07 2018
revised: 30 10 2018
pubmed: 30 11 2018
medline: 27 11 2019
entrez: 29 11 2018
Statut: ppublish

Résumé

Unique features of nanofibers provide enormous potential in the field of biomedical and healthcare applications. Many studies have proven the extreme potential of nanofibers in front of current challenges in the medical and healthcare field. This review highlights the nanofiber technologies, unique properties, fabrication techniques (i.e., physical, chemical, and biological methods), and emerging applications in biomedical and healthcare fields. It summarizes the recent researches on nanofibers for drug delivery systems and controlled drug release, tissue-engineered scaffolds, dressings for wound healing, biosensors, biomedical devices, medical implants, skin care, as well as air, water, and blood purification systems. Attention is given to different types of fibers (e.g., mesoporous, hollow, core-shell nanofibers) fabricated from various materials and their potential biomedical applications.

Identifiants

pubmed: 30485660
doi: 10.1002/mabi.201800256
doi:

Substances chimiques

Biocompatible Materials 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1800256

Subventions

Organisme : Tehran University of Medical Sciences
ID : 94-01-103-28528
Pays : International

Informations de copyright

© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Auteurs

Rahimeh Rasouli (R)

Department of Medical Nanotechnology, Tehran University of Medical Sciences-International Campus, 14177-43373, Tehran, Iran.

Ahmed Barhoum (A)

Faculty of Science, Chemistry Department, Helwan University, 11795, Helwan, Cairo, Egypt.
Institut Européen des Membranes (IEM UMR 5635), ENSCM, CNRS, University of Montpellier, 34090, Montpellier, France.

Mikhael Bechelany (M)

Institut Européen des Membranes (IEM UMR 5635), ENSCM, CNRS, University of Montpellier, 34090, Montpellier, France.

Alain Dufresne (A)

LGP2, Grenoble INP, CNRS, Université Grenoble Alpes, F-38000, Grenoble, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH